Updated:
Aurora Science
AurorA Science is a biotechnology investment company founded in 2020 in Milan, Italy. It provides financial support and industrial expertise to biotechnology...
Overview
AurorA Science is a biotechnology investment company founded in 2020 in Milan, Italy. It provides financial support and industrial expertise to biotechnology start-ups. AurorA Science focuses on the biotechnology and bio-pharma sectors, having made 2 investments to date.
General information
Firm type
Private Equity
Year founded
2020
Location
Region
Europe
Country
Italy
City
Milano
Corporate office
Milano, Italy
Frequently asked questions
What investment stages does Aurora Science typically target?
Aurora Science focuses on early-stage and startup equity investments, according to available research. The firm operates as a generalist venture investor, seeking direct positions in pre-scale companies. Specific stage boundaries — such as seed versus Series A typical check sizes — have not been publicly detailed.
What is the firm's geographic focus?
Aurora Science is headquartered in Milano, Italy, and deploys capital across Europe. Its investment mandate is not limited to a single sub-region, though specific country allocations or portfolio exposures outside Italy remain opaque.
Does Aurora Science participate in fund commitments or only direct deals?
The firm’s documented strategy covers early-stage and venture (general) investments, implying a direct deal orientation. No record of Aurora Science acting as a limited partner in external funds or running a fund-of-funds program has surfaced.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: